A version of this article was originally published by CancerNetwork®. This version has been lightly edited. The use of neoadjuvant chemotherapy (NACT) for less common epithelial ovarian cancers ...

The findings come amidst growing use of the treatment approach. Neoadjuvant chemotherapy (NACT) may be associated with poorer survival outcomes for certain patients with more uncommon types of ...

Neoadjuvant chemotherapy (NACT) is a treatment for advanced ovarian cancer – cancer at stage III or IV. It uses chemo drugs to shrink tumors before any surgery is done to remove them. NACT uses a ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Survival outcomes for patients with high-grade serous ovarian carcinoma may be ...

Receiving treatment at a center with greater use of neoadjuvant chemotherapy was associated with a lower risk of 90-day mortality for patients treated at low-, average-, or high-volume centers.

Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer A multi-institutional ...

—There has been a shift toward greater use of neoadjuvant chemotherapy in patients with advanced ovarian cancer. Is it the right choice? Reviewed by Vrunda Bhavsar Desai, MD, FACOG, Adjunct Assistant ...

"Our main conclusion is that more research is needed to better investigate multimodality therapies and individualize therapy for these high-risk patients…There’s a clear need to advance ...

Abbreviations: MSKCC, Memorial Sloan Kettering Cancer Center; OS, overall survival; CGR, complete gross resection; mos, months. CGR, complete gross resection; PDS, primary debulking surgery. The EORTC ...

Giannopoulos et al. compared the parameters of surgical invasiveness between PDS-CT (n = 29) and NACT (n = 35) in the treatment of stage IIIC/IV ovarian cancer. [21] Patients treated with NACT were ...